SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-23-175031
Filing Date
2023-06-26
Accepted
2023-06-26 16:01:28
Documents
8
Period of Report
2023-08-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d505907ddef14a.htm DEF 14A 1328194
2 GRAPHIC g505907dsp001c.jpg GRAPHIC 832
3 GRAPHIC g505907dsp1a.jpg GRAPHIC 4343
4 GRAPHIC g505907dsp1b.jpg GRAPHIC 3133
5 GRAPHIC g505907g00a05.jpg GRAPHIC 53391
6 GRAPHIC g505907g00a40.jpg GRAPHIC 84446
7 GRAPHIC g505907g00a41.jpg GRAPHIC 74086
8 GRAPHIC g505907g01l07.jpg GRAPHIC 25741
  Complete submission text file 0001193125-23-175031.txt   1669350
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37627 | Film No.: 231042320
SIC: 2834 Pharmaceutical Preparations